Effective planning begins with grading VMS severity, characterizing the sleep complaint, and confirming hormone therapy ...

Limited visit time, minimal sleep medicine training, and widespread self-medication leave many women with menopause-related ...

Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 ...

One question at every visit could prevent strokes in atrial fibrillation, says Geoffrey Barnes, MD, who also previews ...

Annual injections, every-4-month dosing, and a once-monthly pill could reshape HIV prevention. Yet the faculty agree the most ...

The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults ...

Linda Bradley, MD, explains why blind endometrial sampling may miss focal uterine pathology and when persistent abnormal ...

October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart ...

Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank ...

JoAnn Pinkerton, MD, discusses elinzanetant's onset of VMS relief, common adverse effects, and treatment expectations for ...

Black and Hispanic women had higher rates of hormone therapy discontinuation in a new study. Intira Sriprasert, MD, PhD, ...

Only 21.7% of more than 318 000 women initiated systemic hormone therapy (HT) within 12 months of a natural menopause ...